AEterna Zentaris to Present at Upcoming BMO Capital Markets 2008 Focus on Healthcare...

AEterna Zentaris to Present at Upcoming BMO Capital Markets 2008 Focus on
Healthcare Conference and 28th Annual Canaccord Adams Global Growth Conference

QUEBEC CITY, July 31 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.
(NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on
endocrine therapy and oncology, today announced that its Senior Vice President
and Chief Medical Officer, Paul Blake, M.D., will present a company overview
at the upcoming BMO Capital Markets 2008 Focus on Healthcare Conference on
Tuesday, August 5, 2008 at 1:45 pm (eastern time), in Room 3 of the Millennium
Broadway Hotel in New York City.
Furthermore, Professor, Jurgen Engel, Ph.D., Executive Vice President and
Chief Scientific Officer at AEterna Zentaris will also present a company
overview at the 28th Annual Canaccord Adams Global Growth Conference on
Wednesday, August 13, 2008 at 10:00 am (Eastern Time) in the London room of
the Intercontinental Hotel in Boston.
A live webcast of Professor Engel's presentation will be available on
AEterna Zentaris' website at www.aezsinc.com in the Investors section. A
replay will also be available for a period of 30 days on the Company's
website.
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization. News releases and additional information
are available at www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.

Investor relations: Dennis Turpin, CA, Senior Vice President and Chief
Financial Officer, (908) 626-5503, dturpin@aezsinc.com; Media relations: Paul
Burroughs, Director of Communications, (418) 652-8525 ext. 406,
pburroughs@aezsinc.com